Regenerative Biologics Distributor for St. Louis Aesthetic Clinics

Medical director and physician-supervision verification

Medspas operating under physician supervision should confirm with their supervising physician, and with any state-required medical director, that a given product and its intended use fit the practice's licensing structure. Precision Biologics does not make that determination and does not advise on treatment protocols.

Practices should also verify scope-of-practice and supervision requirements with the Missouri State Board of Registration for the Healing Arts and their own counsel.

Vendor qualification and account setup

Dermatology, plastic surgery, and medspa practices typically confirm that a new supplier sells only to licensed accounts and can provide documentation for internal review before a product is approved for use in the practice. Precision Biologics restricts ordering to NPI-verified accounts and provides a certificate of analysis, donor eligibility summary, and lot release record on request.

Regulatory status of exosome products

Exosome products are regulated as biologic drugs under section 351 of the Public Health Service Act. The FDA has stated there are no FDA-approved exosome products, and purchase decisions should be made with that fact and the practice's own regulatory counsel in view.

Cold-chain and shelf-stable shipping options

Cryopreserved formats ship overnight on dry ice from -80 degree C storage in validated containers, while lyophilized formats ship shelf-stable without cryogenic handling. Each unit carries a lot identifier that the practice can log for traceability at the patient record level.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.